1. Home
  2. KTCC vs BLRX Comparison

KTCC vs BLRX Comparison

Compare KTCC & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

N/A

Current Price

$2.50

Market Cap

28.6M

Sector

Technology

ML Signal

N/A

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$3.10

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTCC
BLRX
Founded
1969
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
12.9M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
KTCC
BLRX
Price
$2.50
$3.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$19.00
AVG Volume (30 Days)
36.8K
27.3K
Earning Date
02-03-2026
11-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$435,063,000.00
$12,735,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$2.30
52 Week High
$4.47
$14.70

Technical Indicators

Market Signals
Indicator
KTCC
BLRX
Relative Strength Index (RSI) 40.69 42.76
Support Level $2.40 $2.87
Resistance Level $2.65 $3.36
Average True Range (ATR) 0.13 0.19
MACD 0.01 -0.02
Stochastic Oscillator 35.71 41.08

Price Performance

Historical Comparison
KTCC
BLRX

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: